These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21658472)

  • 1. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.
    Re F; Cambianica I; Zona C; Sesana S; Gregori M; Rigolio R; La Ferla B; Nicotra F; Forloni G; Cagnotto A; Salmona M; Masserini M; Sancini G
    Nanomedicine; 2011 Oct; 7(5):551-9. PubMed ID: 21658472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells.
    Sauer I; Dunay IR; Weisgraber K; Bienert M; Dathe M
    Biochemistry; 2005 Feb; 44(6):2021-9. PubMed ID: 15697227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide.
    Re F; Cambianica I; Sesana S; Salvati E; Cagnotto A; Salmona M; Couraud PO; Moghimi SM; Masserini M; Sancini G
    J Biotechnol; 2011 Dec; 156(4):341-6. PubMed ID: 21763360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries.
    Hülsermann U; Hoffmann MM; Massing U; Fricker G
    J Drug Target; 2009 Sep; 17(8):610-8. PubMed ID: 19694613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis.
    Shubar HM; Dunay IR; Lachenmaier S; Dathe M; Bushrab FN; Mauludin R; Müller RH; Fitzner R; Borner K; Liesenfeld O
    J Drug Target; 2009 May; 17(4):257-67. PubMed ID: 19255896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
    Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
    J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four different peptides to enhance accumulation of liposomes into the brain.
    Qin Y; Zhang Q; Chen H; Yuan W; Kuai R; Xie F; Zhang L; Wang X; Zhang Z; Liu J; He Q
    J Drug Target; 2012 Apr; 20(3):235-45. PubMed ID: 22188312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopeptide-based micellar and liposomal carriers: Influence of surface charge and particle size on cellular uptake into blood brain barrier cells.
    Sydow K; Nikolenko H; Lorenz D; Müller RH; Dathe M
    Eur J Pharm Biopharm; 2016 Dec; 109():130-139. PubMed ID: 27702684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles as permeating vectors for the blood-brain barrier.
    Lien CF; Molnár E; Toman P; Tsibouklis J; Pilkington GJ; Górecki DC; Barbu E
    Biomacromolecules; 2012 Apr; 13(4):1067-73. PubMed ID: 22409486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on nerve growth factor liposomes on crossing blood-brain barrier in vitro and in vivo].
    Xie Y; Ye LY; Cui W; Xu K; Zhang XB; Lou JN; Hou XP
    Yao Xue Xue Bao; 2004 Nov; 39(11):944-8. PubMed ID: 15696939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease.
    Bana L; Minniti S; Salvati E; Sesana S; Zambelli V; Cagnotto A; Orlando A; Cazzaniga E; Zwart R; Scheper W; Masserini M; Re F
    Nanomedicine; 2014 Oct; 10(7):1583-90. PubMed ID: 24333591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting delivery of liposomes with conjugated p-aminophenyl-α-d-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with β-amyloid peptide.
    Kuo YC; Lin CY
    J Drug Target; 2015 Feb; 23(2):147-58. PubMed ID: 25268274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
    Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Wagner S; Büchel C; von Briesen H; Kreuter J
    J Control Release; 2009 Jul; 137(1):78-86. PubMed ID: 19285109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways.
    Neves AR; Queiroz JF; Lima SAC; Reis S
    Bioconjug Chem; 2017 Apr; 28(4):995-1004. PubMed ID: 28355061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active targeting of brain tumors using nanocarriers.
    Béduneau A; Saulnier P; Benoit JP
    Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.
    Michaelis K; Hoffmann MM; Dreis S; Herbert E; Alyautdin RN; Michaelis M; Kreuter J; Langer K
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1246-53. PubMed ID: 16554356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model.
    Balazs Z; Panzenboeck U; Hammer A; Sovic A; Quehenberger O; Malle E; Sattler W
    J Neurochem; 2004 May; 89(4):939-50. PubMed ID: 15140193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.
    Cerletti A; Drewe J; Fricker G; Eberle AN; Huwyler J
    J Drug Target; 2000; 8(6):435-46. PubMed ID: 11328669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.